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This review aims to clear off or bring to the public, any unsubstantiated (smokescreens and mirrors) claims made by manufacturers of
commercial herbal products (CHP) in South Africa. The review further examines production, quality in terms of efﬁcacy and safety as claimed by
the manufacturers and seeks to understand any possibilities of adulteration with modern medicine to these so called African products. There is
evidence of an increase in locally produced CHP containing complex mixtures of several medicinal plants, sold in numerous retail outlets,
including supermarkets and pharmaceutical outlets. The CHPs are available in liquid, capsule and powder forms, packaged professionally, carrying
labels that lists conditions these preparations are used for. Some of the labels list the plant species in the product and in some cases vitamins and
essential elements used for fortiﬁcation.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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The commercialization of traditional medicinal plants in South
Africa can be traced back about 100 years (Van Wyk, 2011).
Amongst the first commercialized plants, the important ones
from a unique heritage of over 3 000 medicinal plant species
include Aloe ferox, A. linearis, Harpagophytum procumbens
and Pelargonium sidoides (Van Wyk, 2011). The products
from such plants have since found their way into the European
and other Western markets. In recent years, a wider range of
indigenous medicinal plants have been packaged and sold in
retail outlets as over-the-counter drugs and products designed not
only to manage health problems but also to allay fears and
anxieties in everyday life (Mander and Le Breton, 2006; Ndhlala
et al., 2011a). As such, the products reach a substantial proportion
of the South African population especially in rural and urban
areas. In that regard, the quality control for the efficacy and safety
of such herbal products becomes essential. However, quality⁎ Corresponding author. Tel.: +27 33 2605130; fax: +27 33 2605897.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
0254-6299/$ -see front matter © 2012 SAAB. Published by Elsevier B.V. All right
doi:10.1016/j.sajb.2012.06.008control, discovery of active constituents in them, and proof of the
efficacies have long been regarded as just but a ‘shot in the dark’,
presenting scientists with tedious and difficult tasks.
Quality of herbal products is defined as the status of the
product that is determined by identity, purity, content, and other
chemical, physical, or biological properties, governed by the
manufacturing processes (Liang et al., 2004). Natural product
constituents used in herbal medicine consist of a vast array of raw
materials hence the capability of variations in these products. This
variability is also caused by differences in growth, geographical
location, processes involving harvesting, drying, and stor-
age. To prove identity and purity, methods of preparation,
physical constants, adulteration, contaminants, moisture, ash
content, packaging, labelling and solvent residues have to be
constantly checked. Strict guidelines have to be followed for the
successful production of a quality herbal product. Among these are
proper botanical identification, phytochemical screening, standard-
ization, packaging and proper labelling.
Commercial herbal preparations, in most cases are mixtures of
selected medicinal and aromatic plants used to treat specific health
conditions. The preparations are manufactured and packaged bys reserved.
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Zulu herbal (muthi) market and in Johannesburg, for supplies to the
rest of the country (Ndhlala et al., 2009). Recently, there has been a
surge in the appearance in shops, pharmacies and on supermarket
shelves of these manufactured herbal products carrying numerous
claims regarding their efficacy and safety. The products range from
single-species products to complex multi-species blends (Mander
and Le Breton, 2006). The products usually take the form of
brightly coloured scented viscous liquids, coloured solids, capsules
and incense sticks. The products are mainly used as general tonics,
good luck charms (“when one wishes for things to go well and/or
to promote good fortune”), protection from evil spirits, attraction of
sexual partners (as well as increase in sexual prowess and appetite)
and emetics (vomiting mixtures) (Ndhlala et al., 2011a). Their
design is based on traditional theories and spiritual concepts i.e.
recipes and preparations that are of African Traditional Medicine
(ATM) origin. However, the packaging and presentations are
modern, but the products lack scientific safety and quality controls
(Ndhlala et al., 2009).
It is understood that some individuals do not only consult
professionals for either physical illnesses, or do they exclusively
consult traditional healers for culturally related problems but also
treat themselves without seeking advice by utilizing over the
counter commercial herbal products. This review seeks to highlight
any possible unsubstantiated (smokescreens and mirrors) claims
faced by over the counter herbal product users in terms of quality
claims made by the manufacturers. In this review, all commercial
herbal products, including brand-name single-species products,
complex multi-species blends, semi- or fully-processed that can be
purchased in herbal shops, pharmacies and supermarkets will be
referred to as commercial herbal preparations (CHP).
2. Evolution of herbal trade
Several centuries ago, traditional remedies mostly consisted
of only single agents/species (Zhang, 1993) but with the
accumulation of therapeutic knowledge and experience,
traditional healers realised that combining diverse natural medi-
cines to constitute a mixture could effectively enhance healing
effects (Gertsch, 2011; Kong et al., 2009).With rapid globalization
and urbanization, there have been notable changes in herbal
medicine trade, especially with the introduction of CHP. With
people getting easy access to education, and as they get involved
in modern occupations, particularly the youth, preferences in
culture and traditions are changing (Ndhlala et al., 2011a).
Traditional healers and herbalists are forced to adapt in order to
accommodate such social changes. It is noticeable that people in
urbanizing societies have desires to use traditional products but
have neither the time nor resources to produce them (Ndhlala et
al., 2011a). Private entrepreneurs around the country are taking
advantage of such situations and are capitalizing on the urbanized
societies by manufacturing and making CHP widely available to
those who need them. Unfortunately, many of these entrepre-
neurs sell products of substandard quality.
Customers are offered either crudely (semi) processed CHPs
that are usually manufactured in small quantities by informal
street traders, market traders or individual traditional healersand are often packaged in recycled bottles with hand-written
labels or some that are on sale in shops which are manufactured
(fully-processed) in large quantities by private entrepreneurs in
industrialized establishments that produce professionally pack-
aged and labelled products (Ndhlala et al., 2009).
2.1. Semi- to full-processed commercial products
Product processing is not only important for adding value but
adds stability to the herbs for longer shelf-life and improved
hygiene (Feiter, 2006). The degree to which a product is processed
depends on the manufacturer, cost involved, the supplier, and other
parties involved in the production process. Fig. 1A–C represents
typical semi-processed CHPs while Fig. 1D and E presents the
professionally packaged and labelled products.
Semi-processed products are usually chopped, ground or boiled
ormaceratedwith water tomake fresh juice, hot and cold infusions,
decoctions, tinctures, pastes and pulverata (Fig. 1A–C). Such
products are unstable and highly perishable reducing the required
time between harvesting and use. Decoctions vary in strengths, the
appropriate ratio of solvent-to-plant material must be used and
toxic ingredients must be neutralized. Semi-processed herbs are
usually packaged into poor quality containers (recycled bottles) or
newspapers and plastic packets.Most cheap plastic containers have
toxic plasticizers such as di(2-ethylhexyl) phthalate (DEHP)
(Nair et al., 2012). DEHP is not chemically bound to the plastic,
hence it readily leaches into the surrounding medium or fluids
(Chen et al., 2004). Furthermore, DEHP is hydrolyzed enzymat-
ically to a mono(2-ethylhexyl) phthalate (MEHP), which is known
to be more toxic than the parent compound (Albro and Lavenhar,
1989).
The process of making manufactured and/or fully-processed
herbal products can be costly and this may impact negatively to
the consumer as they will have to pay more for the products. The
resulting therapies come in several forms, including oral tablets,
capsules, gel caps, extracts and infusions (Fig. 1D and E).
Depending on the target market, different ways of packaging can
be used (quality versus costs). These include glass bottles, for
high value markets, plastic containers and plastic tubes for the
middle to lower income markets.
Different packaging for different target markets can easily be
reflected in Fig. 1A and D. Fig. 1A (intelezi) and D (Tokoloshe
salts) represents lucky charms which can also be used to drive
away evil spirits. The semi-processed intelezi in Fig. 1A is wrapped
in paper bags and is likely sold along the streets while the
Tokoloshe salts in Fig. 1D are manufactured and packaged into
presentable plastics and bottles (one of the products in Fig. 1E) for
higher-market value customers who buy from pharmacies and
supermarkets. In rural areas, the traditional intelezi (equivalent of
the Tokoloshe salts in urban areas) is usually made of a mixture of
bulbous plants, leaves and barks that are placed in a container
(normally a broken used clay-pot) infused in cold water and
sprinkled around the homestead or on the person. Species used for
making intelezi are mainly strongly scented plants (Ndhlala et al.,
2011a). The Tokoloshe salts takes its name from the tokoloshe,
creatures reportedly made from human body parts but very
diminutive. The danger attributed to the Tokoloshe is that it may be
Fig. 1. Semi-processed commercial herbal products (CHP); (A and B) chopped mixtures of plant materials; (C) boiled infusions bottled in cheap plastic containers;
(D and E) a wide range of fully-processed CHP packaged in zipped plastic bag (D) and bottled into different quality containers.
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provides the owner great powers of destruction (Cocks and Dold,
2000). The traditional intelezi is used by ordinary people who are
not prepared to spend more and will get poor quality products
while the Tokoloshe salts are used by mainly business people
who seek protection from the activities of their enemies
associated with sorcery and witchcraft, thus they are prepared to
pay more.
3. Labelling herbal products: Smokescreens and mirrors in
efficacy and safety of herbal products
In the late 19th and early 20th centuries, the food and drug
marketplace around the world were very corrupt when it came
to labelling of products. So much so that some consumers began
to hire their own chemists to certify the quality and purity of foods
and drugs sold within their states. This was aimed at protecting the
consumers against the sale of adulterated and inferior foods and
drugs from outside (Abood and Brushwood, 1994).
Since CHPs are usually mixtures of many constituents, the
active principle(s) is (are), in most cases unknown. Thus product
labels are useful primarily to provide information about the
contents to its users. Unfortunately, consumers have a less chance
of actually getting what is listed on the label, and published
analyses of CHPs have found inconsistencies and deceptive
tendencies by manufacturers concerning what is listed on the label
and what is actually in the bottle (Gilroy et al., 2003). It can then be
concluded that CHPs labels cannot often be trusted to reveal what
is in the container. The lack of consistent labelling on CHPs can be
a source of consumer frustration as they are left to decide safety and
effectiveness for themselves.
The manufacturers of CHPs instead use the labels for branding
and they include colourful images for marketing rather than being
informative. Fig. 2 presents some common labels often found in
CHPs in South Africa. According to the Regulations 9.1 and 40.1of the Medicines and Related Substances Control Act (Number
101 of, 1965) of South Africa, labels should list the active
ingredients and amounts, directions of use such as serving quantity
(dosage) and frequency of intake of the CHP and possible side
effects must be included. Some CHPs also include the term
“standardized” to imply that CHP is uniformly comparable
with other preparations of the same products. In addition to
the above information, the label should include the name and
contact of the manufacturer, packaging agent or distributor. Other
useful information that should be included on the label includes its
intended use and any additive ingredients such as amino acids.
Favourable storage conditions, shelf life or expiry date, warnings
and disclaimer are also equally important (Feiter, 2006).
The CHP business throughout the world is probably riddled
with impure, contaminated and sometimes lethally toxic products
that carry ‘gold plated’ labels likely to win everyone's trust. In the
CHP market in South Africa, for example, several products have
labels claiming multiple uses from a single mixture. Some of the
claims made for one mixture include the use as emetic (vomiting
mixture), good luck charms to be sprayed around the house or
smeared on the whole body or body parts to chase away or cleanse
bad luck, to bring good luck in court cases, in love and to protect
from, chase away, ward off or root out evil spirits and protect from
lightning (Cocks and Dold, 2000). Such claims are not easy to
validate using scientific methods.
Fig. 2 depicts some labels listing multiple uses from a single
CHP. Stameta herbal product (BODicare®) (Fig. 2A and B) is one
such product, listing a total of 29 conditions that can be cured from
administering the product. From an observation point of view,
Stameta is one of the widely used CHP in urban and rural areas,
possibly because of advertising and the colourful label. Ibhubezi
(Pharmachem Pharmaceuticals) (Fig. 2C and D) is also one such
product, used for a wide array of conditions. A study to assess the
antimicrobial and cyclooxygenase (COX-1 and ‐2) effects of
Ibhubezi confirmed its potency (Ndhlala et al., 2009). However,
Fig. 2. Labels of four different CHPs; (A and B) Stameta (BODicare®); (C and D) Ibhubezi (Pharmachem Pharmaceuticals) (label claim the mixture was scientifically
formulated); (E and F) Supreme One Hundred (BODicare®) and (G) Imbiza ephuzwato (KwaNyanga yeZizwe). All the labels list at least 16 conditions that can be
alleviated by administering the product.
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that are listed on Ibhubezi's label. Surprisingly, the work that
followed uncovered the potential of several other CHPs as
antioxidants and antimicrobials agents, as well as inhibitors
of the enzymes HIV-1 reverse transcriptase, acetylcholinesterase
(AChE) and COX (1 and 2) (Ndhlala et al., 2010, 2011b).
However, more tests and quality control methods are required to
ascertain the claimed potency of these CHPs including Ibhubezi.
3.1. Truth, falsehood and evidence: towards the demise of
dishonesty in CHP labels
The information on the label should be regarded as important
as the finished herbal product. Any warnings on the label should
be taken seriously and will help to reduce the risk of inappropriate
uses and side effects (De Smet, 2002). Marketing and advertising
plays a major role in the use of herbal products and must provide
information about natural health products, however, information
obtained through mass media lacks scientific consistency. How
do people know which CHP to take? The question interests
everyone, but the answer lies in mass media and product labels.
In some countries, for example in the USA, CHPmanufacturers
are not able to stifle the consumers into using falsely labelled CHP.
The media, concerned citizens and the scientific community have
beenworking hand in hand to help expose falsely labelled products
that have claims of unfounded cures for several diseases and
conditions including HIV/AIDS, cancer, tuberculosis, syphilis,
narcotic addiction, and a host of other serious as well asself-limited diseases. The influential work was published in the
series Collier's on October 7, back in 1905 entitled "The Great
American Fraud" (Adams, 1905).
In some instances, scientists have exposed popular CHPs
that are of low quality and substandard. An example is the case
of Echinacea preparations that were sold in August 2000 in
Denver, Colorado (USA) which were put to scientific test
resulting in the condemnation of the producers of the CHP for
the poor quality products. The Echinacea samples tested did not
reliably contain the labelled species. The correlation between the
labelled quantity in milligrams of the herb and the measured
milligrams was weak in both standardized and non-standardized
preparations (Gilroy et al., 2003). A similar study of preparations of
Echinacea available in Germany, published in December 2000,
revealed similar results (Osowski et al., 2000). Prior to that, the
Consumer Reports in the USA had conducted one similar study
testing 10 brands of ginseng and their results revealed that some of
the tested brands were made up of extracts of 2 different plants,
Panax subspecies (true ginseng) and Eleutherococcus or Siberian
ginseng, which does not contain the active ginsenosides. They
uncovered shocking evidence that while the milligrams of ginseng
per capsule were clearly defined on the packaging, the concentra-
tion of constituents, or ginsenoside in the CHPs, varied 50-fold
(Consumer Reports, 1995). Recently, the Herbal Flos Lonicerae
(Herbal Xenicol) natural weight loss formula was banned by the
United Kingdom Medicines and Healthcare products Regulatory
Agency (MHRA) following some warnings that a patient in the
UK was hospitalised and several others reported suffering a range
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abdominal pain, as well as insomnia after taking the capsules. The
product was found to be adulterated with a ‘banned but beloved’
slimming agent sibutramine at more than twice the dose that was
normally prescribed before it was removed from the UK market in
2010 (Canada Health- Foreign Product Alert, 2011).
4. What can be done to ensure quality?
Within the context of increased CHP use, product quality,
dosage regulations and standardization becomes enforceable
and herbal products will need to meet health, safety and quality
assurance standards to be marketable (Diederichs et al., 2006).
A number of the developed countries have stringent product
standards that the exporting countries or their own manufacturing
companies of CHP should adhere to. However, the processes to
attain such high standards are very complex and involves
stringent regulatory requirements, availability and suitability of
technical methods for quality control and competent enforcers,
post-marketing quality surveillance, and strict safety monitoring
as well as proper consumer information and education.
It is a generally held myth that herbal products are safe. The
truth is that some herbs can be lethal. In fact, most of the drugs
are noxious compounds produced by the plant for their own
protection from herbivores, microbial and viral attacks. Further-
more, dubious CHP are often adulterated with synthetic prescrip-
tion drugs and/or heavy metals for some reasons better known to
the manufacturers. Such practices then become dangerous to the
unsuspecting consumer, thus the need for strict policies in such
industries.
In South Africa, CHP are controlled by rules and regulations
contained in the Medicine and Related Substances Control Act
[Number 101 of, 1965] and related regulations and Ethnical Rules.
The South African primary agency for the control, regulation
and registration of CHP is the Medicine Control Council
(MCC) (Diederichs et al., 2006). The MCC is appointed by
the Minister of Health and its main purpose is to safeguard
and protect the public through ensuring that all medicines that
are sold and used in South Africa are safe, therapeutically
effective and consistent with acceptable standards of quality.
The question still remains as to how effective are the policing
of these regulations?
Section 14 of the Medicines and Related Control Act clearly
stipulates that any medicine to be sold to the public has to be
registered and the manufacturer should be a pharmaceutical
company registered with the MCC. The manufacturer is bound to
Good Manufacturing Practices (GMP), Good Distributing Prac-
tices (GDP) and Pharmaceutical Ethnical Rules (Diederichs et al.,
2006). It is however, known that manufacturers and herbal
practitioners fear that strict guidelines aimed at improving quality
and safety of CHP could force them out of business. Perhaps the
manufacturers do not have the financial resources even to consider
conducting research or seeking quality approval. They have thus
grouped themselves into a multitude of formal and informal
associations making it difficult for theMCC to engage them and/or
enforce any of the regulations stipulated for the quality control of
CHP (Diederichs et al., 2006). Opportunistic entrepreneurs havesince taken advantage of the lack of formal framework to regulate
the industry and have produced vast numbers of unchecked
products intended for the urban and rural markets (Diederichs et al.,
2006; Ndhlala et al., 2011a).
To mitigate the discrepancy, the government introduced the
Traditional Heath Practitioners Bill which provides an interim
council which sets practice standards for the regulation of
traditional health services. But who can you trust? A decade
ago, eye-brows were raised pertaining to the manner in which
some CHP have been registered and commissioned by the
MCC and the interim council.
Research is being conducted into the quality of many CHP
by institutions and universities throughout South Africa. Most
of these researchers are mainly concerned with validation of
efficacy and safety of herbal medicines including CHP. The
validation of herbal products is a major scientific concern in
South Africa, where quacks and charlatans sell adulterated
CHP (Ndhlala et al., 2011a). There are a number of excellent
methods for the validation of efficacy, safety and iden-
tification of herbs in CHP. Apart from validations, re-
search institutes are also getting into cultivating herbs using
innovative technologies to process raw plant material into
extracts, essential oils, tinctures and other derivatives which
they can sell and/or export to the pharmaceutical, food, bev-
erage and cosmetic markets.4.1. Blue print methods for quality control of CHP
Quality control of CHP is mainly based on the initial
identification and sensory inspection (macroscopic and micro-
scopic examinations) of herbs (plant voucher specimens are a
reliable reference source) as the first step, followed by
identifying small fragments of crude or powdered herbs, and
detection of foreign matter and adulterants (Gomez et al., 2007;
WHO, 2011). During storage, it is important to keep the
material in a clean and hygienic place, so that no contamination
occurs. Special care should be taken to avoid formation of
moulds, since they may produce aflatoxins (WHO, 2011). The
degree of purity of herbal medicines can be achieved by the use
of a vast array of modern chemical analytical methods such as
ultraviolet/visible spectroscopy (UV/VIS), TLC, HPLC, GC,
mass spectrometry (MS), or a combination of GC and MS
(GC/MS/NMR), can be employed (Razmovski-Naumovski et
al., 2010). These blue print methods provide the simplest and
quickest means to establish identity and purity of herbal medicines
(Choi et al., 2002; WHO, 2011).
Chromatographic fingerprinting using TLC is the first step
in analysing CHP made up of complex mixtures. It is not only
powerful but it is also a rapid solution to distinguish between
major chemical classes resulting in simple fingerprints for the
CHP (Zeng et al., 2008). HPLC still remain the best method for
quantitative analysis of complex mixtures such as CHP whilst the
most used techniques for heavy metal determination are Electro-
thermal Atomic Absorption Spectrometry (ETAAS), Inductively
Coupled Plasma Optical Emission Spectrometry (ICPOES) and
ICP-MS (Gomez et al., 2007).
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Proper quality control of CHP hinges mostly on strong
analytical tools augmented by the correct choices of the bioassay
and extracting solvents depends on the nature of the compounds
involved. Several parameters can be used to ascertain quality.
These parameters includes microscopic evaluation which primarily
involves the visual evaluation, which in most cases use a simple
magnifying lens or microscopic analysis to determine the correct
species and/or that the correct part of the species is present. Another
important parameter to look into is the determination of foreign
matter (WHO, 2011). Foreign matter includes moulds, poison-
ous secretions and chemical residues. Other equally important
parameters include the determination of ash, heavy metals,
microbial contaminants, aflatoxins and pesticide residues contam-
ination (WHO, 2011; Zhang et al., 2012). Efficacy testing is
usually used to test whether CHP are safe and effective (Diederichs
et al., 2006), better known as clinical trials.
Clinical trials consist of four important phases which
include; Phase I, designed to test drugs in small groups, using
healthy volunteers (Safety); Phase II, involves a larger group of
test organisms (100–200; Patients); Phase III, make use of even
larger groups of people (Multicentre using N200 patients) and
Phase IV, involves post-market studies to investigate and
provide extra information for example risks and benefits of
the CHP.
In conclusion, over-the-counter medicinal remedies, mostly
CHP, whose production has adopted modern packaging and
marketing practices, is a flourishing trade in South Africa. The
major problem with regard to such products is the quality control
in terms of safety and efficacy. The major concern is centred on
the manufacturing practices, including possible contamination,
substitution, incorrect preparation and dosages during use. Other
grave concerns include intentional addition of toxic substances,
possible interactions with modern synthetic prescription drugs,
and either intentional or unintentional mislabelling as well as the
presence of natural toxic contaminants.
As researchers continue to investigate the safety and effective-
ness of herbal medicines, more is revealed about both their
usefulness and pitfalls. Perhaps legislators should also try to gain
back the trust of the public by registering and commissioning CHP
in a transparent manner and press for effective policing in order to
protect consumers from potentially harmful practices.Acknowledgements
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